Jim Simons Immunovant, Inc. Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Immunovant, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 189,000 shares of IMVT stock, worth $5.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

189,000

Previous 388,100 51.3%

Holding current value

$5.2 Million

Previous $10.2 Million 49.25%

% of portfolio

0.01%

Previous 0.02%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$27.51 - $27.51 $5.48 Million - $5.48 Million	-199,100 Reduced 51.3%	189,000 $5.2 Million
Q2 2024 Aug 09, 2024	BUY	$25.1 - $31.61 $1.21 Million - $1.53 Million	48,400 Added 14.25%	388,100 $10.2 Million
Q1 2024 May 13, 2024	BUY	$30.27 - $43.79 $9.73 Million - $14.1 Million	321,400 Added 1756.28%	339,700 $11 Million
Q4 2023 Feb 13, 2024	SELL	$31.31 - $44.19 $6.36 Million - $8.97 Million	-203,100 Reduced 91.73%	18,300 $771,000
Q3 2023 Nov 14, 2023	SELL	$18.55 - $39.96 $4.57 Million - $9.85 Million	-246,400 Reduced 52.67%	221,400 $8.5 Million
Q2 2023 Aug 11, 2023	SELL	$14.2 - $23.75 $345,230 - $577,410	-24,312 Reduced 4.94%	467,800 $8.87 Million
Q1 2023 May 12, 2023	BUY	$15.27 - $19.72 $2.26 Million - $2.92 Million	148,012 Added 43.01%	492,112 $7.63 Million
Q4 2022 Feb 13, 2023	SELL	$6.59 - $17.75 $55,356 - $149,100	-8,400 Reduced 2.38%	344,100 $6.11 Million
Q3 2022 Nov 14, 2022	BUY	$3.93 - $6.37 $78,207 - $126,763	19,900 Added 5.98%	352,500 $1.97 Million
Q2 2022 Aug 12, 2022	BUY	$3.38 - $5.65 $783,822 - $1.31 Million	231,900 Added 230.29%	332,600 $1.3 Million
Q1 2022 May 13, 2022	BUY	$5.06 - $8.77 $420,485 - $728,787	83,100 Added 472.16%	100,700 $555,000
Q4 2021 Feb 11, 2022	BUY	$7.33 - $9.32 $129,008 - $164,032	17,600 New	17,600 $150,000
Q1 2021 May 13, 2021	SELL	$13.08 - $49.6 $73,248 - $277,760	-5,600 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$36.36 - $52.71 $203,616 - $295,176	5,600 New	5,600 $259,000
Q3 2020 Nov 13, 2020	SELL	$22.61 - $38.9 $820,743 - $1.41 Million	-36,300 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$13.87 - $28.44 $503,481 - $1.03 Million	36,300 New	36,300 $884,000

Others Institutions Holding IMVT

# of Institutions

211

Shares Held

66.9M

Call Options Held

2.3M

Put Options Held

631K

View Full List

About Immunovant, Inc.

Ticker IMVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,077,000
Market Cap $3.55B
Description
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...

More about IMVT

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account